agilon health (NYSE:AGL) Stock Price Up 8.6% – Should You Buy?

agilon health, inc. (NYSE:AGL)’s share price traded up 8.6% on Thursday . The company traded as high as $3.71 and last traded at $3.73. 7,115,106 shares traded hands during trading, an increase of 32% from the average session volume of 5,374,423 shares. The stock had previously closed at $3.43.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on AGL. William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a research note on Wednesday, October 2nd. Barclays decreased their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday, November 11th. Royal Bank of Canada restated an “outperform” rating and set a $3.00 price target on shares of agilon health in a research note on Tuesday, November 19th. Finally, Evercore ISI decreased their price objective on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Two investment analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $4.03.

agilon health Stock Performance

The company has a market capitalization of $1.48 billion, a PE ratio of -3.81 and a beta of 0.53. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The company has a 50 day moving average price of $2.37 and a 200 day moving average price of $3.49.

agilon health (NYSE:AGL) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter last year, the business earned ($0.06) earnings per share. Equities analysts forecast that agilon health, inc. will post -0.59 EPS for the current year.

Insider Transactions at agilon health

In related news, Director John William Wulf acquired 45,000 shares of the business’s stock in a transaction on Thursday, December 5th. The shares were purchased at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Diana Mckenzie acquired 12,500 shares of agilon health stock in a transaction that occurred on Monday, November 25th. The stock was acquired at an average cost of $2.28 per share, with a total value of $28,500.00. Following the completion of the purchase, the director now owns 51,319 shares in the company, valued at approximately $117,007.32. This represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 90,000 shares of company stock worth $198,100. 3.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On agilon health

Several large investors have recently made changes to their positions in AGL. State Street Corp grew its position in agilon health by 3.0% in the third quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after acquiring an additional 215,733 shares in the last quarter. Geode Capital Management LLC grew its holdings in agilon health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after buying an additional 84,889 shares during the last quarter. Citigroup Inc. lifted its holdings in shares of agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after acquiring an additional 1,083,492 shares during the period. Finally, AQR Capital Management LLC grew its stake in shares of agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.